Here is what the editors at Physician’s Briefing selected as an important COVID-19 developments for you and your apply for the week of Dec. 13 to 17, 2021. This roundup contains the newest analysis information from journal research and different trusted sources that’s most certainly to have an effect on medical apply. Severe Mental Illness Tied to Poorer COVID-19 Outcomes
FRIDAY, Dec. 17, 2021 (HealthDay News) — People with extreme psychological sickness have larger dangers for COVID-19 an infection, hospitalization, and mortality, in line with a research printed on-line Dec. 7 in Molecular Psychiatry.
Read Full Text
Pfizer Vaccine Disappoints in Children Ages 2 to five Years
FRIDAY, Dec. 17, 2021 (HealthDay News) — Two doses of a pediatric Pfizer-BioNTech COVID-19 vaccine didn’t spur an ample immune response in kids ages 2 to five years, the businesses introduced Friday.
Read Full Text
Myocarditis, Myopericarditis Risk Up After SARS-CoV-2 Vaccination
FRIDAY, Dec. 17, 2021 (HealthDay News) — SARS-CoV-2 mRNA vaccination is related to a considerably elevated danger for myocarditis or myopericarditis amongst men and women receiving mRNA-1273 and amongst females receiving BNT162b2, however absolute charges are low, in line with a research printed on-line Dec. 16 in The BMJ.
Read Full Text
Hyperbaric Oxygen Helps Treat Severe Hypoxemia in COVID-19
FRIDAY, Dec. 17, 2021 (HealthDay News) — Hyperbaric oxygen remedy is efficient for sufferers with extreme hypoxemia related to COVID-19, in line with a research printed on-line Dec. 14 within the Emergency Medicine Journal.
Read Full TextCOVID-19 Vaccination More Likely With Provider RecommendationTHURSDAY, Dec. 16, 2021 (HealthDay News) — Adults who obtain a supplier suggestion for COVID-19 vaccination usually tend to have obtained a number of doses of COVID-19 vaccine, in line with analysis printed within the Dec. 17 situation of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Read Full TextEarly CDC COVID-19 Tests Were Not Only Contaminated, however FlawedTHURSDAY, Dec. 16, 2021 (HealthDay News) — Along with being contaminated, there was additionally a primary design flaw in COVID-19 testing kits created by the U.S. Centers for Disease Control and Prevention early within the pandemic, a brand new company evaluate reveals.Read Full TextCDC Panel Advises That Other Vaccines Are Preferred Over J&J ShotTHURSDAY, Dec. 16, 2021 (HealthDay News) — Following continued reviews of a uncommon however life-threatening clotting situation linked to the Johnson & Johnson COVID-19 vaccine, a federal advisory panel on Thursday really helpful that the Pfizer and Moderna pictures be the popular selections for Americans.Read Full TextU.S. Army COVID-19 Vaccination Rate Nears 98 PercentTHURSDAY, Dec. 16, 2021 (HealthDay News) — Nearly 98 p.c of the U.S. Army lively-obligation power had obtained no less than one COVID-19 vaccine dose as of Wednesday’s deadline for necessary vaccination, officers stated Thursday. However, greater than 3,800 troopers have refused to get a shot and will begin being discharged from the navy subsequent month, in line with an Army assertion.Read Full TextImmune Response May Vary With Choice of COVID-19 BoosterTHURSDAY, Dec. 16, 2021 (HealthDay News) — Immune response might differ with the selection of COVID-19 vaccine used for a 3rd dose or booster following two doses of ChAdOx1 nCoV-19 or Pfizer BioNTech BNT162b2, in line with a research printed on-line Dec. 2 in The Lancet.Read Full TextNatural Immunity Protects Against SARS-CoV-2 ReinfectionTHURSDAY, Dec. 16, 2021 (HealthDay News) — Natural immunity protects in opposition to reinfection with the alpha and beta variants of extreme acute respiratory syndrome coronavirus 2, in line with a research printed on-line Dec. 15 within the New England Journal of Medicine.Read Full TextPersistent Dyspnea After COVID-19 May Indicate Cardiac DysfunctionTHURSDAY, Dec. 16, 2021 (HealthDay News) — Patients with persistent dyspnea one yr after restoration from the acute section of COVID-19 might have irregular coronary heart operate, in line with a research introduced at EuroEcho 2021, a scientific congress of the European Society of Cardiology, held from Dec. 9 to 11 in Berlin.Read Full TextAAP Issues Guidance for Children’s Emotional Needs During COVID-19WEDNESDAY, Dec. 15, 2021 (HealthDay News) — In steerage issued by the American Academy of Pediatrics, suggestions are introduced to assist pediatricians help the emotional and behavioral wants of kids, youngsters, and households through the COVID-19 pandemic.Read Full TextAntibody Response to SARS-CoV-2 Wanes Among Dialysis PatientsWEDNESDAY, Dec. 15, 2021 (HealthDay News) — For individuals receiving dialysis, the antibody response to extreme acute respiratory syndrome coronavirus 2 wanes by way of 5 to 6 months and is related to a danger for breakthrough an infection, in line with a research printed on-line Dec. 14 within the Annals of Internal Medicine.Read Full TextCDC Warns of Coming Omicron WaveWEDNESDAY, Dec. 15, 2021 (HealthDay News) — The omicron variant is spreading quickly within the United States and will set off an enormous wave of COVID-19 infections as early as January, federal well being officers stated Tuesday.Read Full TextCOVID-19 Severity Does Not Differ for Patients With Skin ConditionsWEDNESDAY, Dec. 15, 2021 (HealthDay News) — For sufferers with psoriasis, vitiligo, atopic dermatitis, and persistent urticaria, COVID-19 severity doesn’t differ, however remedy of COVID-19 might have an effect on the course of pores and skin illness, in line with a letter to the editor printed within the January 2022 situation of the Journal of the European Academy of Dermatology and Venereology.Read Full TextTwo Doses of mRNA-1273 Effective Against SARS-CoV-2 VariantsWEDNESDAY, Dec. 15, 2021 (HealthDay News) — Two doses of mRNA-1273 vaccine are extremely efficient in opposition to a number of extreme acute respiratory syndrome coronavirus 2 variants, in line with a research printed on-line Dec. 15 in The BMJ.Read Full TextRisk Factors Identified for Developing COVID-19WEDNESDAY, Dec. 15, 2021 (HealthDay News) — Risk elements independently related to elevated odds of growing COVID-19 embody Asian/Asian British versus White ethnicity, family overcrowding, and elevated physique mass index, in line with a research printed on-line Nov. 30 in Thorax.Read Full TextCOVID-19 Breakthrough Infections More Common in Immunocompromised PatientsWEDNESDAY, Dec. 15, 2021 (HealthDay News) — COVID-19 vaccine breakthrough infections are uncommon amongst totally vaccinated people, however they’re extra frequent and extra extreme in those that are immunocompromised, in line with a research printed on-line Nov. 30 within the Journal of Medical Economics.Read Full TextPfizer Says Final Data Show COVID-19 Pill Stays Strong Against Severe IllnessTUESDAY, Dec. 14, 2021 (HealthDay News) — Pfizer Inc. introduced Tuesday {that a} last evaluation reveals its experimental antiviral tablet Paxlovid sharply diminished hospitalizations and deaths amongst COVID-19 sufferers at excessive danger for extreme sickness.Read Full TextCDC: Only Half of U.S. Nursing Home Residents Have Received BoostersTUESDAY, Dec. 14, 2021 (HealthDay News) — As COVID-19 instances surge nationwide, solely about half of totally vaccinated nursing dwelling residents have obtained a vaccine booster dose, the U.S. Centers for Disease Control and Prevention reviews.Read Full TextOmicron Resists Pfizer Vaccine however Causes Less Severe DiseaseTUESDAY, Dec. 14, 2021 (HealthDay News) — Compared with earlier coronavirus variants, omicron seems to trigger much less extreme sickness, however is extra proof against the Pfizer vaccine, researchers at South Africa’s largest well being insurer report.Read Full TextCalifornia Brings Back Indoor Mask MandateTUESDAY, Dec. 14, 2021 (HealthDay News) — A statewide indoor masks mandate shall be reintroduced in California on Wednesday and final one month, officers in America’s largest state stated Monday.Read Full TextLess Than Half of Over 65s Received Booster From Aug. 13 to Nov. 19TUESDAY, Dec. 14, 2021 (HealthDay News) — About 44 p.c of individuals aged 65 years or older obtained a booster or extra major dose of COVID-19 vaccine throughout Aug. 13 to Nov. 19, 2021, within the United States, in line with analysis printed within the Dec. 10 early-launch situation of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Read Full TextReport Highlights Characteristics of Omicron SARS-CoV-2 Variant in U.S.TUESDAY, Dec. 14, 2021 (HealthDay News) — Surveillance and traits of the extreme acute respiratory syndrome coronavirus 2 omicron variant are described in a report printed within the Dec. 10 early-launch situation of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Read Full Text~40 Percent With Confirmed COVID-19 Are AsymptomaticTUESDAY, Dec. 14, 2021 (HealthDay News) — The proportion of asymptomatic extreme acute respiratory syndrome coronavirus 2 infections is 0.25 and 40.50 p.c amongst people present process testing and people with confirmed COVID-19, respectively, in line with a evaluate printed on-line Dec. 14 in JAMA Network Open.Read Full TextBritish Study Shows Vaccines Weaken Against Omicron, however Boosters HelpMONDAY, Dec. 13, 2021 (HealthDay News) — The capability of two-dose COVID-19 vaccines to guard in opposition to symptomatic an infection by the omicron variant falls considerably quick, however a booster shot gives appreciable safety, in line with the primary actual-world research of how efficient vaccines are in opposition to the quickly spreading new type of the coronavirus. The findings are preliminary and haven’t been peer-reviewed or printed in a scientific journal.Read Full TextU.S. COVID-19 Death Toll Passes 800,000MONDAY, Dec. 13, 2021 (HealthDay News) — The COVID-19 loss of life toll within the United States reached 800,000 on Monday, and one skilled believes it would probably hit 1 million sooner or later in 2022.Read Full TextConvalescent Plasma Not Efficacious in Hospitalized COVID-19 PatientsMONDAY, Dec. 13, 2021 (HealthDay News) — For hospitalized sufferers with COVID-19 receiving noninvasive supplemental oxygen, COVID-19 convalescent plasma isn’t efficacious in contrast with placebo, in line with a research printed on-line Dec. 13 in JAMA Internal Medicine.Read Full TextCOVID-19 Vaccine Uptake Lower Among Black Health Care ProvidersMONDAY, Dec. 13, 2021 (HealthDay News) — Black, nonphysician well being care personnel have been much less prone to obtain the COVID-19 vaccine within the first 4 months of availability versus clinicians of different races, in line with a research printed on-line Dec. 1 in JAMA Network Open.Read Full TextFor Earlier Variants, Severe COVID-19 Less Likely at ReinfectionMONDAY, Dec. 13, 2021 (HealthDay News) — Compared with major an infection with extreme acute respiratory syndrome coronavirus 2, reinfections have 90 p.c decrease odds of extreme, crucial, or deadly illness based mostly on knowledge for the variants circulating through the research interval, in line with a letter to the editor printed on-line Nov. 24 within the New England Journal of Medicine.Read Full TextReport Shows World Ill-Prepared for Next PandemicMONDAY, Dec. 13, 2021 (HealthDay News) — The world isn’t prepared to forestall or cope with one other pandemic as a result of many countries should not taking the required steps to organize for what is probably going an inevitable future situation, a brand new report reveals. The Global Health Security index — an evaluation of preparedness for varied well being emergencies and issues — is produced by the Nuclear Threat Initiative, Economist Impact, and the Johns Hopkins Center for Health Security on the Bloomberg School of Public Health.Read Full Text
Physician’s Briefing Weekly Coronavirus Roundup – Consumer Health News
